Sign up for a free trial now

Login
Subscribe
Take a FREE Trial

About Us
Contact us
RSS

20 May 2013

Search

The Pharma Letter

Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe

Oceana Therapeutics Articles

Salix Pharma to buy Oceana for $300 million; posts 3rd-qtr profit

9 November 2011

Dr Reddy’s gains Indian rights to Oceana’s Deflux

18 May 2011

Showing 1-2 of 2 articles

Go to beginning

Previous

1

Next

Go to end

Hot Topics
Most Read

Elan makes "transformational" acquisitions and a divestment
Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
SciClone gains China rights to Zensun's Neucardin
Bristol-Myers' data on Yervoy and nivolumab causes a stir
Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member

Elan makes "transformational" acquisitions and a divestment
Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
SciClone gains China rights to Zensun's Neucardin
Bristol-Myers' data on Yervoy and nivolumab causes a stir
Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member

© 2013 thepharmaletter.com

Home
RSS
About Us
Subscribe
Terms and Conditions
Article Archive

Site powered by WORKSsitebuilder CMS